213 related articles for article (PubMed ID: 31407478)
1. Clinical outcomes and survival following lung transplantation in patients with pulmonary Langerhans cell histiocytosis.
Wajda N; Zhu Z; Jandarov R; Dilling DF; Gupta N
Respirology; 2020 Jun; 25(6):644-650. PubMed ID: 31407478
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes and survival following lung transplantation in patients with lymphangioleiomyomatosis.
Khawar MU; Yazdani D; Zhu Z; Jandarov R; Dilling DF; Gupta N
J Heart Lung Transplant; 2019 Sep; 38(9):949-955. PubMed ID: 31303421
[TBL] [Abstract][Full Text] [Related]
3. Lung transplantation for pulmonary langerhans' cell histiocytosis: a multicenter analysis.
Dauriat G; Mal H; Thabut G; Mornex JF; Bertocchi M; Tronc F; Leroy-Ladurie F; Dartevelle P; Reynaud-Gaubert M; Thomas P; Pison C; Blin D; Stern M; Bonnette P; Dromer C; Velly JF; Brugière O; Lesèche G; Fournier M
Transplantation; 2006 Mar; 81(5):746-50. PubMed ID: 16534477
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary Langerhans cell histiocytosis-associated pulmonary hypertension: clinical characteristics and impact of pulmonary arterial hypertension therapies.
Le Pavec J; Lorillon G; Jaïs X; Tcherakian C; Feuillet S; Dorfmüller P; Simonneau G; Humbert M; Tazi A
Chest; 2012 Nov; 142(5):1150-1157. PubMed ID: 22459770
[TBL] [Abstract][Full Text] [Related]
5. Clinical Research of Pulmonary Langerhans Cell Histiocytosis in Children.
Wang D; Cui L; Li ZG; Zhang L; Lian HY; Ma HH; Zhao YZ; Zhao XX; Wang TY; Zhang R
Chin Med J (Engl); 2018 Aug; 131(15):1793-1798. PubMed ID: 30058575
[TBL] [Abstract][Full Text] [Related]
6. Echocardiographic and clinical characteristics of pulmonary hypertension complicating pulmonary Langerhans cell histiocytosis.
Chaowalit N; Pellikka PA; Decker PA; Aubry MC; Krowka MJ; Ryu JH; Vassallo R
Mayo Clin Proc; 2004 Oct; 79(10):1269-75. PubMed ID: 15473409
[TBL] [Abstract][Full Text] [Related]
7. Bronchoalveolar lavage for the diagnosis of Pulmonary Langerhans cell histiocytosis.
Lommatzsch M; Bratke K; Stoll P; Mülleneisen N; Prall F; Bier A; Virchow JC
Respir Med; 2016 Oct; 119():168-174. PubMed ID: 27692140
[TBL] [Abstract][Full Text] [Related]
8. Determinants of survival in pulmonary Langerhans' cell granulomatosis (histiocytosis X). Groupe d'Etude en Pathologie Interstitielle de la Société de Pathologie Thoracique du Nord.
Delobbe A; Durieu J; Duhamel A; Wallaert B
Eur Respir J; 1996 Oct; 9(10):2002-6. PubMed ID: 8902457
[TBL] [Abstract][Full Text] [Related]
9. How I manage pulmonary Langerhans cell histiocytosis.
Lorillon G; Tazi A
Eur Respir Rev; 2017 Sep; 26(145):. PubMed ID: 28877978
[TBL] [Abstract][Full Text] [Related]
10. Morphometric Study of Pulmonary Arterial Changes in Pulmonary Langerhans Cell Histiocytosis.
Bois MC; May AM; Vassallo R; Jenkins SM; Yi ES; Roden AC
Arch Pathol Lab Med; 2018 Aug; 142(8):929-937. PubMed ID: 30040456
[TBL] [Abstract][Full Text] [Related]
11. Clinical analysis for 15 patients with pulmonary Langerhans cell histiocytosis and literature review.
Zhang L; Ouyang R
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Mar; 47(3):334-343. PubMed ID: 35545326
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes of adult pulmonary Langerhans cell histiocytosis: a prospective cohort.
Benattia A; Bugnet E; Walter-Petrich A; de Margerie-Mellon C; Meignin V; Seguin-Givelet A; Lorillon G; Chevret S; Tazi A
Eur Respir J; 2022 May; 59(5):. PubMed ID: 34675043
[TBL] [Abstract][Full Text] [Related]
13. [Double-lung transplantation in 15 patients with pulmonary hypertension].
López-Meseguer M; Román A; Monforte V; Bravo C; Solé J; Morell F
Arch Bronconeumol; 2009 Aug; 45(8):366-70. PubMed ID: 19410347
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of Exercise Limitation and Prevalence of Pulmonary Hypertension in Pulmonary Langerhans Cell Histiocytosis.
Heiden GI; Sobral JB; Freitas CSG; Pereira de Albuquerque AL; Salge JM; Kairalla RA; Fernandes CJCDS; Carvalho CRR; Souza R; Baldi BG
Chest; 2020 Dec; 158(6):2440-2448. PubMed ID: 32615192
[TBL] [Abstract][Full Text] [Related]
15. Survival following lung transplantation for silicosis and other occupational lung diseases.
Singer JP; Chen H; Phelan T; Kukreja J; Golden JA; Blanc PD
Occup Med (Lond); 2012 Mar; 62(2):134-7. PubMed ID: 22071439
[TBL] [Abstract][Full Text] [Related]
16. Pneumothorax in Patients with Pulmonary Langerhans Cell Histiocytosis.
Radzikowska E; Błasińska-Przerwa K; Wiatr E; Bestry I; Langfort R; Roszkowski-Śliż K
Lung; 2018 Dec; 196(6):715-720. PubMed ID: 30187131
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes and survival following lung transplantation in patients with Alpha-1 antitrypsin deficiency.
Riley L; Lascano J
Respir Med; 2020 Oct; 172():106145. PubMed ID: 32911139
[TBL] [Abstract][Full Text] [Related]
18. Changes in pulmonary artery pressure affect survival differently in lung transplant recipients who have pulmonary hypertension or chronic obstructive pulmonary disease.
O'Keefe KL; Kilic A; Pope-Harman A; Hayes D; Kirkby S; Higgins RS; Whitson BA
Exp Clin Transplant; 2014 Aug; 12(4):283-9. PubMed ID: 25095706
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary Artery Pressure and Benefit of Lung Transplantation in Adult Cystic Fibrosis Patients.
Hayes D; Tumin D; Daniels CJ; McCoy KS; Mansour HM; Tobias JD; Kirkby SE
Ann Thorac Surg; 2016 Mar; 101(3):1104-9. PubMed ID: 26687141
[TBL] [Abstract][Full Text] [Related]
20. Severe pulmonary hypertension in histiocytosis X.
Fartoukh M; Humbert M; Capron F; Maître S; Parent F; Le Gall C; Sitbon O; Hervé P; Duroux P; Simonneau G
Am J Respir Crit Care Med; 2000 Jan; 161(1):216-23. PubMed ID: 10619823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
